(Q41092833)

26 September 2017

title

The Inhibitory Effect of Aspirin on Platelet and Vascular Prostaglandins in Rats cannot be Completely Dissociated (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

15 April 2023

1 reference

S. Villa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383131

15 April 2023

M. Livio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383131

15 April 2023

G. de Gaetano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A383131

15 April 2023

language of work or name

English

0 references

publication date

1 July 1979

1 reference

full work available at URL

26 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.1979.tb01151.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1979.tb01151.x/fullpdf

15 April 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

British Journal of Haematology

15 April 2023

published in

1 reference

26 September 2017

volume

42

1 reference

26 September 2017

issue

3

1 reference

26 September 2017

page(s)

425-431

1 reference

Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Prostacyclin-like activity and bleeding in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Acetylation of prostaglandin synthase by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Arachidonic acid-induced human platelet aggregation and prostaglandin formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Territoriality in the white rhinoceros (Ceratotherium simum) Burchell.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Are agents affecting platelet functions clinically useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Normal prostacyclin-like activity in vascular tissues from thrombocytopenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Prostacyclin-like activity in rat vascular tissues. fast, long-lasting inhibition by treatment with lysine acetylsalicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

An enzymatic mechanism for the antithrombotic and antihemostatic actions of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1979.TB01151.X

Cultured human skin fibroblasts and arterial cells produce a labile platelet-inhibitory prostaglandin

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

Metabolism of [14C]arachidonic acid by human platelets

15 April 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

Inhibition of platelet prostaglandin synthetase by oral aspirin

15 April 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin

15 April 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

Aspirin and thromboembolism--a possible dilemma.

15 April 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

Arachidonic Acid Causes Sudden Death in Rabbits

15 April 2023

15

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

Formation of an intermediate in prostaglandin biosynthesis and its association with the platelet release reaction

15 April 2023

17

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

Prostacyclin and atherosclerosis in rats

15 April 2023

24

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1979.TB01151.X

15 April 2023

Identifiers

1 reference

26 September 2017

1 reference